$CCEL

CRYO CELL INTERNATIONAL INC

CIK:0000862692|SEC Filings

Consolidated Statements of Income - USD ($)	3 Months Ended		9 Months Ended
Consolidated Statements of Income - USD ($)	Aug. 31, 2026	Aug. 31, 2025	Aug. 31, 2026	Aug. 31, 2025
Revenue	$ 7,824,156	$ 7,825,432	$ 23,283,386	$ 23,723,155
Costs and Expenses:
Cost of sales	1,613,213	1,801,419	4,946,364	5,642,546
Selling, general and administrative expenses	3,779,109	3,876,159	13,408,955	12,772,301
Research, development and related engineering	53,624	61,625	219,166	291,479
Depreciation and amortization	184,479	185,693	552,695	567,648
Total costs and expenses	5,630,425	5,924,896	19,127,180	19,273,974
Operating Income	2,193,731	1,900,536	4,156,206	4,449,181
Other Income (Expense):
Gains (losses) gains on marketable securities	69,755	(193,886)	(98,684)	(604,619)
Other income	267	17,565	8,947	34,562
Interest expense	(438,305)	(538,219)	(1,342,931)	(1,584,307)
Total other (expense) income	(368,283)	(714,540)	(1,432,668)	(2,154,364)
Income before income tax expense	1,825,448	1,185,996	2,723,538	2,294,817
Income tax expense	(554,958)	(436,588)	(851,354)	(906,769)
Net income	$ 1,270,490	$ 749,408	$ 1,872,184	$ 1,388,048
Net income per common share - basic	$ 0.16	$ 0.09	$ 0.23	$ 0.17
Weighted average common shares outstanding - basic	8,062,650	8,057,780	8,057,778	8,073,303
Net income per common share - diluted	$ 0.16	$ 0.09	$ 0.23	$ 0.17
Weighted average common shares outstanding - diluted	8,065,142	8,073,654	8,057,920	8,126,614
Processing and Storage Fees [Member]
Revenue	$ 7,650,234	$ 7,820,877	$ 23,008,793	$ 23,558,484
Public Banking Revenue [Member]
Revenue	135,000	4,119	182,895	128,886
Product Revenue [Member]
Revenue	$ 38,922	$ 436	$ 91,698	$ 35,785

Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Aug. 31, 2026	Aug. 31, 2025
Cash flows from operating activities:
Net income	$ 1,872,184	$ 1,388,048
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	728,374	742,231
Loss on sale of property and equipment	0	48,304
Losses on marketable securities	98,684	604,619
Compensatory element of stock options	315,967	374,198
Provision for doubtful accounts	923,595	780,197
Amortization of debt issuance costs	15,326	15,657
Amortization of operating lease right-of-use asset	290,593	295,654
Changes in assets and liabilities:
Accounts receivable	(911,294)	(304,483)
Prepaid expenses	82,233	19,125
Inventory	(48,763)	79,730
Other current assets	(450,979)	109,604
Deposits and other assets, net	(53,388)	(92,144)
Accounts payable	(449,861)	741,407
Accrued expenses	(1,712,652)	(3,525,297)
Operating lease liability	(327,646)	(317,744)
Deferred revenue	3,267,134	3,238,687
Net cash from operating activities	3,639,507	4,197,793
Cash flows from investing activities:
Purchases of property and equipment	(201,645)	(163,249)
Sale of property and equipment	0	115,000
Purchases of marketable securities	(900,042)	(3,160,145)
Sale of marketable securities	975,079	2,522,711
Net cash from (used) in investing activities	(126,608)	(685,683)
Cash flows used in financing activities:
Treasury stock purchases	0	(169,502)
Repayments of note payable	(129,517)	(110,235)
Repayment of line of credit	(3,500,000)	(7,120,000)
Proceeds from the exercise of stock options	23,250	23,101
Proceeds from line of credit	1,200,000	6,800,000
Dividends paid	0	(3,231,227)
Net cash used in financing activities	(2,406,267)	(3,807,863)
Increase (Decrease) in cash and cash equivalents	1,106,632	(295,753)
Cash and cash equivalents - beginning of period	319,031	560,960
Cash and cash equivalents - end of period	1,425,663	265,207
Supplemental non cash operating activities
Lease liability arising from right-of-use asset	0	396,163
Supplemental cash flow information
Interest	1,330,944	1,533,485
Income taxes	$ 1,395,084	$ 2,833,737

Consolidated Balance Sheets - USD ($)	Aug. 31, 2026	Nov. 30, 2025
Current Assets
Cash and cash equivalents	$ 1,425,663	$ 319,031
Marketable securities	2,803,292	2,977,013
Accounts receivable (net of allowance for doubtful accounts of $4,366,902 and $4,306,410, respectively)	6,833,879	6,846,180
Prepaid expenses	490,985	573,218
Inventory, current portion	533,557	408,794
Other current assets	1,084,964	633,985
Total current assets	13,172,340	11,758,221
Property and Equipment-net	20,541,106	21,034,372
Other Assets
Intangible assets, net	829,611	863,074
Inventory, net of current portion	700,000	776,000
Goodwill	1,941,411	1,941,411
Deferred tax assets	23,620,711	23,620,711
Operating lease right-of-use asset	529,033	819,626
Deposits and other assets, net	968,487	915,099
Total other assets	28,589,253	28,935,921
Total assets	62,302,699	61,728,514
Current Liabilities
Accounts payable	2,420,910	2,870,771
Accrued expenses	2,565,375	4,278,027
Note payable	199,184	183,650
Line of credit	0	2,300,000
Current portion of operating lease liability	426,861	430,221
Deferred revenue	9,719,618	9,730,318
Total current liabilities	15,331,948	19,792,987
Other Liabilities
Deferred revenue, net of current portion	54,252,512	50,974,678
Note payable, net of current portion and debt issuance costs	8,040,405	8,170,130
Operating lease long-term liability	150,342	474,628
Long-term liability - revenue sharing agreements	875,000	875,000
Other liabilities	47,020	47,020
Total other liabilities	63,365,279	60,541,456
Total liabilities	78,697,227	80,334,443
Commitments and contingencies (Note 9)	0	0
Stockholders' Deficit
Preferred stock	0	0
Common stock ($.01 par value, 20,000,000 authorized; 14,884,619 issued and 8,062,650 outstanding as of August 31, 2026 and 14,877,119 issued and 8,055,150 outstanding as of November 30, 2025)	148,846	148,771
Additional paid-in capital	45,047,738	44,708,596
Treasury stock, at cost	(25,025,058)	(25,025,058)
Accumulated deficit	(36,566,054)	(38,438,238)
Total stockholders' deficit	(16,394,528)	(18,605,929)
Total liabilities and stockholders' deficit	62,302,699	61,728,514
Series A Junior Participating Preferred Stock [Member]
Stockholders' Deficit
Preferred stock	$ 0	$ 0